Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial lipodystrophy and renal disease.

P Lenane1, G Murphy

  • 1Dermatology Department, Beaumont Hospital, Dublin, Ireland.

Clinical and Experimental Dermatology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: An audit of out of hours interventional vascular radiology.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2003
Same author

Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts.

The British journal of dermatology·2003
Same author

Investigation of the C242T polymorphism of NAD(P)H oxidase p22 phox gene and ischaemic heart disease using family-based association methods.

Clinical science (London, England : 1979)·2003
Same author

ADAM 33: just another asthma gene or a breakthrough in understanding the origins of bronchial hyperresponsiveness?

Thorax·2003
Same author

High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon.

Prostate cancer and prostatic diseases·2003
Same author

Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis.

Osteoarthritis and cartilage·2002
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles

Partial lipodystrophy is a rare genetic disorder causing fat loss. Early identification through specific biomarkers and recognizing associated kidney and autoimmune conditions is crucial for patient management.

Area of Science:

  • Genetics and rare diseases
  • Endocrinology and metabolism
  • Nephrology and immunology

Background:

  • Partial lipodystrophy is a rare genetic disorder.
  • It presents with autosomal recessive and familial forms.
  • Characterized by gradual loss of subcutaneous fat.

Observation:

  • Cutaneous findings include subtle, progressive fat loss from the face and upper body.
  • Biochemical markers like low C3 and C5 levels, and nephritic factor are diagnostic indicators.
  • Associated systemic conditions include mesangiocapillary glomerulonephritis and increased autoimmune disease incidence.

Findings:

  • Biomarkers such as low complement component 3 (C3) and complement component 5 (C5), along with nephritic factor, aid in diagnosis.
  • Patients are prone to developing mesangiocapillary glomerulonephritis.

Related Experiment Videos

  • There is a higher incidence of autoimmune diseases in affected individuals.

    • Implications:

    • Early recognition of partial lipodystrophy is vital for timely diagnosis.
    • Prompt management can address potentially life-threatening systemic complications.
    • Understanding the genetic basis and associated conditions improves patient outcomes.